| Late Dr. Major S.K. Lal, commenced the business of providing pathology services and maintaining a blood bank in the year 1949 through sole proprietorship M/s Central Clinical Laboratory and M/s Blood Bank Transfusion Centre. The business of diagnostic and related healthcare tests and services now continues to be provided by the Company. Subsequently, Late Dr. Major S.K. Lal and (Hony.) Brig. Dr. Arvind Lal entered into a partnership under the name 'Central Clinical Laboratory', pursuant to a partnership deed dated March 21, 1975, with the partnership deemed to have commenced from December 1, 1974. The partnership firm was formed to provide pathology services under the name `Central Clinical Laboratory' and to maintain a blood bank for the supply of blood to patients and hospitals under the name `Blood Transfusion Centre', both to be undertaken at the Registered Office of the Company. On
December 5, 1977, following the demise of Late Dr. Major S.K. Lal, Late Ms. Vimla Lal, wife of Late Dr. Major S.K. Lal, was inducted into the partnership with (Hony.) Brig. Dr. Arvind Lal. Following Late Ms. Vimla Lal's demise, Dr. Vandana Lal was inducted into the partnership by a deed of partnership dated January 2, 2007. Accordingly, as on date, Central Clinical Laboratory is a 50:50 partnership between Dr. Vandana Lal and (Hony.) Brig. Dr. Arvind Lal. the Company was incorporated as `Dr. Lal PathLabs Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation granted by the RoC on February 14, 1995 at Delhi. The business of the partnership firm Central Clinical Laboratory is now undertaken by the Company, while Central Clinical Laboratory does not undertake any business operations. the Company was converted into a public company pursuant to a special resolution of the shareholders of the Company at an EGM held on August 7, 2015. Consequently, the name of the Company was changed to `Dr. Lal PathLabs Limited' and a fresh certificate of incorporation pursuant to the change of name was granted by the RoC on August 19, 2015.
Awards and accreditations :
2001
-Received the ISO 9001:2008 certification for the quality management system for performance of routine and advanced diagnostic pathology testing services, including in clinical trials.
2002
-Fully accredited by the College of American Pathologists' Laboratory Accreditation Program.
2008
-Awarded the CNBC TV18 Emerging India Award 2008 by ICICI Bank Business Banking in the pharmaceuticals and chemicals category.
2010
-Franchisor of the Year in healthcare, at the Franchise Plus Awards.
-Honourable mention in the healthcare category at the Milagrow Trailblazers Brand Innovator Awards.
2012
-Diagnostic Service Provider Company of the Year, by Frost & Sullivan at the 4th Annual India Healthcare Excellence Awards.
-Named a Computerworld Honours Laureate by the Computerworld Honours Program for innovative use of information technology to conduct research, develop new diagnostic methods and services and improve quality and access of patients to healthcare.
2013
-Best Diagnostic Company in India at the VC Circle Healthcare Summit.
2014
-Received the ISO 27001:2013 certification for the information management system for providing data center services and supporting functions.
-Received an NABL certificate of accreditation under standard ISO 15189:2012 for "Medical Laboratories - Requirements for Quality and Competence" for medical testing, for National Reference Laboratory.
2015
-Data Quest Technology Award for Excellence in the implementation and use of technology for business benefits in the 'Cloud' category.
-Received the certificate of affiliation from the Healthcare Sector Skill Council for role as medical laboratory technician in relation to institute at Gurgaon, Haryana, India.
Major events and milestones :
2005 & 2007
-Investment by WestBridge I Investments Holdings.
2008
-Acquisition of Paliwal Medicare Private Limited and Paliwal Diagnostics Private Limited.
2010
-Establishment of the National Reference Laboratory.
2010 & 2013
-Investment pursuant to purchase of shares by Wagner Limited from WestBridge I Investment Holdings.
2013
-Investment pursuant to purchase of shares by WestBridge Crossover Fund, LLC from WestBridge I Investment Holdings.
-Investment by SIH.
2014
-Acquisition of APL Clinical Institute of Clinical Laboratory & Research Private Limited.
2015
-Amalgamation of Sanya Chemicals Private Limited, Amolak Diagnostics Private Limited, Medex Healthcare Private Limited, Medicave Diagnostic Centre Private Limited, Medicave Medical Systems Private Limited and the Company.
2016
-Dr Lal PathLabs Presents First Trimester Screening Test for Screening Prenatal Disorders
-Dr Lal PathLabs Enhanced Liver Fibrosis Test For Mapping Liver Functionality
-Dr Lal PathLabs is the First Private Lab in India to Introduce Electron Microscopy
2017
-Dr Lal PathLabs is Amalgameted with Ria and Pathology Private Limited
2018
-Amalgamation of Shree Computerised Pathology Laboratory, Modern Diagnostics & Modern Lab
2021
-Dr Lal PathLabs Launches Bangalore Reference Laboratory.
2023
-NCLT has given approval for Amalgamation between Dr. Lal PathLabs Limited and APL Institute of Clinical Laboratory & Research Private Limited.
2024
-NCLT, Allahabad Bench sanctioned the Scheme of Amalgamation between two Subsidiary Companies of Dr. Lal PathLabs Limited.
|